Trp53-KO 基因敲除小鼠

1. Jonkers, J, Meuwissen, R, van der Gulden, H, van der Valk, M, Berns, A. . Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. In Nature genetics, 29, 418-25. doi:. https://pubmed.ncbi.nlm.nih.gov/11694875/

2. Ossa, Carlos Andrés, Molina, Gustavo, Cock-Rada, Alicia María. 2016. Li-Fraumeni syndrome. In Biomedica : revista del Instituto Nacional de Salud, 36, 182-7. doi:10.7705/biomedica.v36i3.2793. https://pubmed.ncbi.nlm.nih.gov/27622479/

3. Gupta, Amit, Shah, Karan, Oza, Manisha J, Behl, Tapan. 2018. Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment. In Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 109, 484-492. doi:10.1016/j.biopha.2018.10.155. https://pubmed.ncbi.nlm.nih.gov/30551517/

4. Nahari, Dorit, McDaniel, Lisa D, Task, Laurie B, Velasco-Miguel, Susana, Friedberg, Errol C. . Mutations in the Trp53 gene of UV-irradiated Xpc mutant mice suggest a novel Xpc-dependent DNA repair process. In DNA repair, 3, 379-86. doi:. https://pubmed.ncbi.nlm.nih.gov/15010313/

5. Roth, J A, Swisher, S G, Meyn, R E. . p53 tumor suppressor gene therapy for cancer. In Oncology (Williston Park, N.Y.), 13, 148-54. doi:. https://pubmed.ncbi.nlm.nih.gov/10550840/